Evaluating progress and addressing actions to eliminate industrially produced trans-fatty acids in the Americas

Objective. To evaluate the progress toward the 2023 target for the elimination of industrially produced transfatty acids (IP-TFA) in the Region of the Americas and to highlight the achievements of the four strategic lines of action from the Plan of Action for the Elimination of IP-TFA 2020-2025. Met...

Full description

Bibliographic Details
Published in:Revista Panamericana de Salud Pública
Main Authors: Sofía Rincón-Gallardo Patiño, Steven Constantinou, Carmen Gorlick, Fabio da Silva Gomes
Format: Article in Journal/Newspaper
Language:English
Spanish
Portuguese
Published: Pan American Health Organization 2022
Subjects:
legislation
food
trans fatty acids
food policy
cardiovascular diseases
americas
Medicine
R
Arctic medicine. Tropical medicine
RC955-962
Public aspects of medicine
RA1-1270
Arctic
Online Access:https://doi.org/10.26633/RPSP.2022.130
https://doaj.org/article/7b6d142399d44c6ba6cabe69df54e3d6
Description
Summary:Objective. To evaluate the progress toward the 2023 target for the elimination of industrially produced transfatty acids (IP-TFA) in the Region of the Americas and to highlight the achievements of the four strategic lines of action from the Plan of Action for the Elimination of IP-TFA 2020-2025. Methods. A survey based on the World Health Organization (WHO) REPLACE package was used to collect data. The REPLACE package outlines six strategic action areas (Review, Promote, Legislate, Assess, Create, Enforce) to support the prompt, complete, and sustained elimination of IP-TFA from the food supply. Information was cross-checked and updated until December 2021. Results. Thirty countries in the Region responded to the survey between November 2019 and July 2020, an 85.7% response rate. As of December 2021, 21 additional indicators of the Regional Plan of Action were met, out of which, four consisted of new enactments of PAHO/WHO best practice policies for the elimination of IP-TFA by countries since baseline data was collected in 2018. This has resulted in a 63.0% increase in the proportion of the population in the Americas protected from consuming IP-TFA in 2021, compared to the baseline in 2018. Conclusion. Despite results showing progress in the Region, actions are needed to strengthen country capacity building and strategies to eliminate IP-TFA and fully achieve the 2023 goal.

Similar Items